Concepedia
Statistics
Publications
8
Citations
475
H-Index
Active since
2017
Affiliations
Universität Hamburg(Current)
University Medical Center Hamburg-Eppendorf
University Cancer Center Hamburg
University Hospital Cologne
Institut für Hämatopathologie Hamburg
Janna-Lisa Velthaus is an author at Universität Hamburg specializing in medicine, oncology, and immunotherapy.
Publications per year
2017–2024
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
Melanie Janning, Franca Kobus, Anna Babayan et al. · Cancers · 2019 · 138 citations · Full text
Medicine, Cancer Biology, Oncology +17
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B
Mark Wroblewski, R. Bauer, Miguel Cubas Córdova et al. · Nature Communications · 2017 · 75 citations · Full text
Medicine, Immunology, Oncology +17
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
Felix Carl Saalfeld, Carina Wenzel, Petros Christopoulos et al. · Journal of Thoracic Oncology · 2021 · 64 citations · Full text
Medicine, Immunology, Oncology +14
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
Denis Horgan, Giuseppe Curigliano, Olaf Rieß et al. · Journal of Personalized Medicine · 2022 · 60 citations · Full text
Medicine, Molecular Medicine, Oncology +17
Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
Annkathrin Hanssen, Carlotta Riebensahm, Malte Mohme et al. · Cancers · 2018 · 56 citations · Full text
Medicine, Clinical Sciences, Oncology +17
1–5 of 8